Novartis Groupe France S.A., a prominent subsidiary of the global healthcare leader Novartis AG, is headquartered in France and operates extensively across Europe and beyond. Founded in 1996, the company has established itself within the pharmaceutical industry, focusing on innovative medicines, generics, and biosimilars.
Novartis is renowned for its commitment to research and development, delivering unique therapies in areas such as oncology, cardiology, and immunology. The company’s core products, including groundbreaking treatments for chronic diseases, set it apart in a competitive market.
With a strong market position, Novartis has achieved numerous accolades for its contributions to healthcare, consistently ranking among the top pharmaceutical companies worldwide. Its dedication to improving patient outcomes underscores its pivotal role in advancing medical science.
+86 vs industry average
Novartis Groupe France S.A.’s score of 94 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Novartis Groupe France S.A.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Food Waste Composting is among the most carbon-intensive industries
Industry performance
The Food Waste Composting industry has increased its overall emissions by 246% since 2019
Reported emissions
No reported emissions data is available for Novartis Groupe France S.A. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Novartis Groupe France S.A.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Novartis Groupe France S.A. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Novartis AG
Carbon Disclosure Project
Inherited from Novartis AGThe Climate Pledge
Inherited from Novartis AGUN Global Compact Climate Champions initiative
RE 100
Inherited from Novartis AGClimate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Novartis Groupe France S.A. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project